The outcome could be countered by the undesirable effects of CD47 ECD binders on autoimmunity, which are shared with other checkpoint-blocking molecules [186], and by agnostic signaling via CD47 in non-cancer cells that limits essential processes [187,188]. This evidence concerns the gene CD47 and cancer.